Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1994 1
2000 1
2001 2
2002 1
2003 5
2004 5
2005 5
2006 4
2007 1
2008 5
2009 12
2010 6
2011 16
2012 13
2013 21
2014 20
2015 18
2016 24
2017 19
2018 16
2019 28
2020 33
2021 45
2022 51
2023 43
2024 23
2025 44
2026 4

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

398 results

Results by year

Filters applied: . Clear all
Page 1
Long-term benefit from high-dose ifosfamide in sarcoma depends on sustained prior control and timely intervention: a machine learning analysis.
Hoberger M, Zuber RL, Burkhard-Meier A, Di Gioia D, Jurinovic V, Völkl M, Güler SE, Albertsmeier M, Klein A, Dürr HR, Schmidt-Hegemann NS, Knösel T, Kunz WG, von Bergwelt-Baildon M, Lindner LH, Berclaz LM. Hoberger M, et al. Among authors: von bergwelt baildon m. J Cancer Res Clin Oncol. 2026 Jan 8;152(1):34. doi: 10.1007/s00432-025-06410-8. J Cancer Res Clin Oncol. 2026. PMID: 41504936 Free PMC article.
Impact of spleen volume and volume change in non-Hodgkin lymphoma treated with chimeric antigen receptor t-cell therapy.
Quell C, Kunz WG, Blumenberg V, Rejeski K, Bücklein VL, Ingenerf M, Schmidt C, Sheikh GT, Brendel M, Ricke J, von Bergwelt-Baildon M, Subklewe M, Winkelmann M. Quell C, et al. Among authors: von bergwelt baildon m. Cancer Treat Res Commun. 2025 Dec 18;46:101080. doi: 10.1016/j.ctarc.2025.101080. Online ahead of print. Cancer Treat Res Commun. 2025. PMID: 41496263 Free article.
Time of Day of CAR T-Cell Infusion and Outcomes in Large B-Cell Lymphoma.
Luan D, Valid OB, Beyar-Katz O, Tix T, Golan-Accav N, Alhomoud M, Avigdor A, Bücklein VL, Cohen L, Dahi PB, Einarsdottir S, Elimelech J, Escribano Serrat S, Falchi L, Fei T, Giralt SA, Gomez-Llobell M, Goy A, Horesh N, Israeli S, Kruk L, Leslie LA, Lue JK, Marcus R, Nagler A, Palomba ML, Park JH, Raj SS, Reddy ST, Romancik JT, Rosenbaum E, Salles GA, Scordo M, Shah GL, Shimoni A, von Bergwelt-Baildon M, Perales MA, Subklewe M, Greenbaum U, Ip A, Ram R, Rejeski K, Shouval R. Luan D, et al. Among authors: von bergwelt baildon m. Blood. 2025 Dec 23:blood.2025031476. doi: 10.1182/blood.2025031476. Online ahead of print. Blood. 2025. PMID: 41489404
What can claims data tell us about risk factors and survival of patients with hepatocellular carcinoma? Insights from a German population-based study.
Becht S, Ben Khaled N, Schrodi S, von Bergwelt-Baildon M, Buggisch P, Crispin A, Hofmann WP, Marschall U, Mayerle J, Mörtl B, Orabi S, Philipp A, Trojan J, Weiglein T, De Toni EN, Berger-Thürmel K. Becht S, et al. Among authors: von bergwelt baildon m. Front Oncol. 2025 Dec 16;15:1650982. doi: 10.3389/fonc.2025.1650982. eCollection 2025. Front Oncol. 2025. PMID: 41476582 Free PMC article.
Real-world analysis of immune checkpoint inhibitor efficacy and response predictors in patients treated at the CCCMunichLMU outpatient clinic.
Dorman K, Breitenwieser K, Fischer L, Zhang D, Probst V, Weiss L, Heinrich K, Kunz WG, Holch JW, Gießen-Jung C, Haas M, Boeck S, von Bergwelt-Baildon M, Landfarth T, Hornung R, Casuscelli J, Berger-Thürmel K, Heinemann V, Westphalen CB, Reischer A. Dorman K, et al. Among authors: von bergwelt baildon m. Sci Rep. 2025 Dec 8;15(1):43269. doi: 10.1038/s41598-025-30220-0. Sci Rep. 2025. PMID: 41361351 Free PMC article.
Treatment gaps and survival outcomes of hepatocellular carcinoma: insights from a nationwide, claims-based study.
Schrodi S, Berger-Thürmel K, Becht S, von Bergwelt-Baildon M, Buggisch P, Hofmann WP, Marschall U, Lange CM, Reiter FP, Mayerle J, Mörtl B, Orabi S, Philipp A, Trojan J, Weiglein T, de Toni EN, Ben Khaled N. Schrodi S, et al. Among authors: von bergwelt baildon m. Ther Adv Med Oncol. 2025 Oct 18;17:17588359251363202. doi: 10.1177/17588359251363202. eCollection 2025. Ther Adv Med Oncol. 2025. PMID: 41142475 Free PMC article.
398 results